Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Noda

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pharmacology & Therapeutics|May 16, 2015
Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitorsTomohiro Terada, Satoshi Noda, Ken-Ichi Inui
Biological & Pharmaceutical Bulletin|July 5, 2022
Dose Individualization of Oral Multi-Kinase Inhibitors for the Implementation of Therapeutic Drug MonitoringSatoshi Noda, Shin-Ya Morita, Tomohiro Terada
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirusKazuo Tanaka, Sadaaki Sawamura, Tadayuki Satoh, et al.
Journal of Pharmaceutical Health Care and Sciences|April 24, 2025
Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational studyYoshinori Wakasugi, Yoshito Ikeda, Satoshi Noda, et al.
Biological & Pharmaceutical Bulletin|April 3, 2020
Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive StudySatoshi Dote, Daisuke Yamaguchi, Daiki Hira, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
Reduction in gastrointestinal toxicity by gastric secretion inhibitors during S-1 monotherapy for patients with gastric cancerYugo Chisaki, Satoshi Noda, Daiki Hira, et al.
Journal of Pharmaceutical Sciences|January 25, 2025
Potential risk factors of protein aggregation in syringe handling during antibody drug dilution for intravenous administrationMasakazu Fukuda, Shino Nagae, Toru Takarada, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2013
Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinomaSatoshi Noda, Makoto Shioya, Daiki Hira, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel diseaseShin Saitoh, Satoshi Noda, Yuji Aiba, et al.
Microbiology and Immunology|January 9, 2003
Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine modelYuji Aiba, Hiroki Ishikawa, Keiko Shimizu, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pharmacology & Therapeutics|May 16, 2015
Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitorsTomohiro Terada, Satoshi Noda, Ken-Ichi Inui
Biological & Pharmaceutical Bulletin|July 5, 2022
Dose Individualization of Oral Multi-Kinase Inhibitors for the Implementation of Therapeutic Drug MonitoringSatoshi Noda, Shin-Ya Morita, Tomohiro Terada
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirusKazuo Tanaka, Sadaaki Sawamura, Tadayuki Satoh, et al.
Journal of Pharmaceutical Health Care and Sciences|April 24, 2025
Efficacy of 5-hydroxytryptamine 3 receptor antagonists versus metoclopramide for preventing nausea and vomiting during azacitidine chemotherapy in patients with myelodysplastic syndromes or acute leukemia: a retrospective observational studyYoshinori Wakasugi, Yoshito Ikeda, Satoshi Noda, et al.
Biological & Pharmaceutical Bulletin|April 3, 2020
Thyroid Dysfunction Related to the Antiangiogenic VEGFR2-Binding Monoclonal Antibody Ramucirumab: A Series of 14 Cases and a Descriptive StudySatoshi Dote, Daisuke Yamaguchi, Daiki Hira, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
Reduction in gastrointestinal toxicity by gastric secretion inhibitors during S-1 monotherapy for patients with gastric cancerYugo Chisaki, Satoshi Noda, Daiki Hira, et al.
Journal of Pharmaceutical Sciences|January 25, 2025
Potential risk factors of protein aggregation in syringe handling during antibody drug dilution for intravenous administrationMasakazu Fukuda, Shino Nagae, Toru Takarada, et al.
Cancer Chemotherapy and Pharmacology|May 16, 2013
Pharmacokinetic interaction between sorafenib and prednisolone in a patient with hepatocellular carcinomaSatoshi Noda, Makoto Shioya, Daiki Hira, et al.
Clinical and Diagnostic Laboratory Immunology|January 5, 2002
Bacteroides ovatus as the predominant commensal intestinal microbe causing a systemic antibody response in inflammatory bowel diseaseShin Saitoh, Satoshi Noda, Yuji Aiba, et al.
Microbiology and Immunology|January 9, 2003
Role of internalization in the pathogenicity of Shiga toxin-producing Escherichia coli infection in a gnotobiotic murine modelYuji Aiba, Hiroki Ishikawa, Keiko Shimizu, et al.
Pageof 5